GE HealthCare (GEHC) stock
Health Care · Health Care Equipment
GE HealthCare (GEHC) is a Health Care Equipment company in the Health Care sector, headquartered in Chicago, Illinois. As of October 23, 2026, GEHC closed at $71.45, a market capitalization of $32.27 billion, the 309th largest company in the S&P 500. Over the last twelve months it generated $21.27 billion in revenue (+6% year over year) and $1.58 billion in free cash flow. The stock trades at 16.4x trailing earnings and 13.2x forward earnings.
- 1-year total return: -7.3% (dividends reinvested)
- 52-week range: $58.75 – $89.77
- Gross margin 39.5%, operating margin 15.0%
- Dividend yield: 0.22%, 1 straight years of increases
- FI Handbook report card: C across 10 metrics
- 41st largest of 60 Health Care stocks in the S&P 500
GEHC price chart
1Y price change: -7.5% (price only; total returns below include dividends)
| Total return | 1M | YTD | 1Y | 3Y | 5Y | 10Y | MAX |
|---|---|---|---|---|---|---|---|
| GEHC | +8.2% | -12.7% | -7.3% | +3.9% | — | — | +4.8% |
Dividends reinvested. 3Y and longer are annualized; MAX is annualized since 2022.
GEHC key statistics
- Market cap
- $32.3B
- #309 in S&P 500
- P/E (TTM)
- 16.4x
- Forward P/E
- 13.2x
- EPS (TTM)
- $4.35
- Revenue (TTM)
- $21.3B
- +6%
- Free cash flow
- $1.6B
- Gross margin
- 39.5%
- Operating margin
- 15.0%
- Return on equity
- 19.4%
- Dividend yield
- 0.22%
- 52-week range
- $58.75 – $89.77
- Beta
- 0.85
- Price / sales
- 1.5x
- EV / EBITDA
- 11.4x
- Debt / equity
- 0.94x
- Employees
- 54,000
GEHC report card
CTen fundamentals graded A to F against fixed thresholds. Not a buy or sell rating.
- Revenue growth5.8%C
- Gross margin39.5%C
- Operating margin15.0%C
- FCF margin7.4%D
- Return on equity19.4%B
- Net debt / EBITDA2.4xD
- Forward P/E13.2xA
- PEG ratio1.8xC
- Shareholder yield0.8%D
- Share count change / yr0.2%C
GE HealthCare Technologies financials
Revenue went from $17.6B in fiscal 2021 to $20.6B in fiscal 2025, growing 4.1% a year.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $17.6B | $18.3B | $19.6B | $19.7B | $20.6B |
| Gross profit | $7.2B | $7.2B | $7.9B | $8.2B | $8.2B |
| Operating income | $2.8B | $2.5B | $2.4B | $2.6B | $2.8B |
| Net income | $2.2B | $1.9B | $1.6B | $2.0B | $2.1B |
| EPS (diluted) | $4.95 | $4.22 | $3.03 | $4.34 | $4.55 |
| Buybacks | — | — | $0 | $0 | $200.0M |
| Dividends paid | $0 | $0 | $41.0M | $55.0M | $64.0M |
| Diluted shares | 454.0M | 454.0M | 458.0M | 459.0M | 458.0M |
Source: SEC filings (10-K XBRL). EPS and share counts are split-adjusted.
What's priced into GEHC?
A reverse DCF asks what growth the current price requires. With an enterprise value of $40.7B and $1.6B of trailing free cash flow, GE HealthCare Technologies needs to grow free cash flow about 17.0% a year for ten years (fading to 3.0% terminal growth) to earn a 10% annual return.
P/E ratio history
Current 15.7x vs. median 18.2x (10th–90th percentile 14.2x–28.8x).
A model, not a forecast or advice. Small changes in assumptions move the answer a lot.
GEHC dividend
- Dividend yield
- 0.22%
- Annual dividend
- $0.16
- Years of increases
- 1
- 5-yr dividend growth
- —
- per year
- Payout ratio
- 3%
- Payments per year
- 4
Regular dividends per share by calendar year; special dividends excluded. Current year omitted until complete.
GEHC analyst price targets
20 analysts' average 12-month target is $82.70 (+16% vs. $71.45). Targets range from $70.00 to $96.00. 73% rate it a buy.
GEHC earnings
Next report: October 28, 2026. GE HealthCare Technologies has beaten EPS estimates 1 quarters in a row. Last quarter's revenue was $5.3B (+6% year over year).
| Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|
| Jul 29, 2026 | $1.04 | $1.13 | +9.1% |
| Apr 29, 2026 | $1.05 | $0.99 | -5.7% |
| Feb 4, 2026 | $1.40 | $1.44 | +3.0% |
| Oct 29, 2025 | $1.05 | $1.07 | +2.2% |
| Jul 30, 2025 | $0.92 | $1.06 | +15.5% |
| Apr 30, 2025 | $0.91 | $1.01 | +10.6% |
| Feb 13, 2025 | $1.26 | $1.45 | +14.8% |
| Oct 30, 2024 | $1.05 | $1.14 | +8.3% |
Stocks like GEHC
| Name | Today | 1Y | Mkt cap | P/E | |
|---|---|---|---|---|---|
 ABT Abbott Laboratories | +1.16% | -16% | $179.4B | 38.6x | Compare |
 ISRG Intuitive Surgical | +1.90% | -18% | $159.8B | 54.7x | Compare |
 MDT Medtronic plc. | -1.22% | +5% | $122.0B | 23.4x | Compare |
 SYK Stryker | +0.02% | -19% | $117.8B | 31.8x | Compare |
 BSX Boston Scientific | -0.70% | -55% | $66.2B | 18.5x | Compare |
 BDX Becton, Dickinson and | -0.75% | +39% | $54.2B | 46.3x | Compare |
 EW Edwards Lifesciences Corporatio | -1.13% | +16% | $51.3B | 53.0x | Compare |
 IDXX IDEXX Laboratories | -1.13% | -12% | $44.1B | 39.4x | Compare |
GEHC news
- Global Breast Cancer Screening and Diagnostics Market, 2026-2036 | AI Imaging and Wider Screening Push Breast-Cancer Diagnostics Toward $12 Billion · Oct 23, 2026
- GE HealthCare Technologies (GEHC) vs. DHR and MDT: Can a $23.9B Backlog and AI Innovation Drive a Healthcare Re-Rating? · Oct 22, 2026
- Here's What to Expect From GE HealthCare’s Next Earnings Report · Oct 21, 2026
- Body Composition Analyzers Market Size and Global Forecast to 2031 | Obesity and Preventive Care Fuel Demand for Body Composition Analyzers · Oct 21, 2026
- GE HealthCare announces five new global collaborations to advance the next generation of theranostics imaging · Oct 20, 2026
GEHC stock FAQ
What is GEHC's market cap?
GE HealthCare's market capitalization is $32.27 billion as of October 23, 2026, ranking 309th in the S&P 500.
What is GEHC's P/E ratio?
GEHC trades at a trailing price-to-earnings ratio of 16.4x and a forward P/E of 13.2x. Its median P/E over the period we track is 18.2x.
Does GEHC pay a dividend?
Yes. GE HealthCare pays $0.16 per share a year, a 0.22% yield. It has raised its dividend 1 years in a row.
How much has GEHC stock returned?
Including reinvested dividends, GEHC returned -7.3% over one year through October 23, 2026.
Is GEHC stock overvalued?
At today's price, a reverse discounted cash flow model (10% discount rate, 3% terminal growth) implies GE HealthCare must grow free cash flow about 17% a year for the next decade. Whether that is achievable decides if the stock is cheap or expensive. This is a model, not advice.
What is the GEHC price target?
20 analysts cover GEHC with an average 12-month price target of $82.70, +16% from the current price. 73% of them rate it a buy.
When does GEHC report earnings?
GE HealthCare is expected to report earnings on October 28, 2026. It has beaten EPS estimates 1 quarters in a row.
How many employees does GE HealthCare have?
GE HealthCare has about 54,000 full-time employees, or $393,815 of revenue per employee.
Sources: SEC EDGAR filings, Yahoo Finance market data (delayed), FI Handbook calculations. Last close October 23, 2026. Methodology